Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address ...

(Reuters) -Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the ...

In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...

U.S. drugmakers Bristol Myers and Merck & Co, and their European counterparts Sanofi and Roche all reported first-quarter ...

Clinical-stage company targeting fundamental drivers of inflammation, autoimmunity and fibrosis, founded by Versant Ventures and Novartis Venture Fund- ...

Brabeck-Letmathe, 80, spent his career at Nestlé. He became a controversial figure after sharing his views on water as a ...

The pharmaceutical and diagnostics company slightly exceeded expectations in the first quarter, driven by its pharmaceutical ...

Repertoire will obtain an upfront payment of $35m from Genentech, with the potential for up to $730m in additional milestones ...

Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...

The EHL Open Innovation Summit 2025 – First edition EHL is excited to announce the inaugural EHL Open Innovation Summit, taking place on ...

Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s ...